We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

110 hedge funds and large institutions have $152M invested in VanEck Biotech ETF in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 31 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1% less funds holding

Funds holding: 111 → 110 (-1)

4.05% less ownership

Funds ownership: 37.62% → 33.56% (-4.1%)

16% less capital invested

Capital invested by funds: $180M → $152M (-$28.5M)

39% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 31

Holders
110
Holders Change
-1
Holders Change %
-0.9%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
19
Reduced
31
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VWM
Valley Wealth Managers
New Jersey
+$3.03M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.17M
3
JMPWA
JP Morgan Private Wealth Advisors
California
+$892K
4
Bank of America
Bank of America
North Carolina
+$840K
5
FFP
FourThought Financial Partners
Florida
+$631K

Top Sellers

Rank Fund Capital Flow
1
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$9.93M
2
TIA
Traphagen Investment Advisors
New Jersey
-$9.21M
3
MJRIC
Mogy Joel R Investment Counsel
California
-$5.76M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.8M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
CT
76
Caldwell Trust
Florida
$66.2K – – –
William Blair & Company
77
William Blair & Company
Illinois
$66.2K – – –
NSIM
78
North Star Investment Management
Illinois
$64.6K – – –
Carson Wealth (CWM LLC)
79
Carson Wealth (CWM LLC)
Nebraska
$62K +$2.08K +13 +3%
LFASL
80
Lugano Financial Advisors SA (LFA)
Switzerland
$60K – – –
BCV
81
Banque Cantonale Vaudoise
Switzerland
$51K – – –
FDCDDQ
82
Federation des caisses Desjardins du Quebec
Quebec, Canada
$46.7K – – –
US Bancorp
83
US Bancorp
Minnesota
$46.1K +$23.3K +146 +97%
HI
84
Harbour Investments
Wisconsin
$38.9K -$4.15K -26 -9%
AF
85
Arrow Financial
New York
$38.9K – – –
TC
86
Truvestments Capital
Florida
$38.9K – – –
Bank of Montreal
87
Bank of Montreal
Ontario, Canada
$37.6K -$5.59K -35 -13%
AIM
88
Anchor Investment Management
South Carolina
$24.9K -$799 -5 -3%
First Manhattan
89
First Manhattan
New York
$23.4K – – –
EDRH
90
Edmond de Rothschild Holding
Switzerland
$20.2K – – –
AF
91
Allworth Financial
California
$18.7K – – –
CG
92
Cutler Group
California
$17K +$16K +100 +667%
Fidelity Investments
93
Fidelity Investments
Massachusetts
$16.9K – – –
FCMT
94
Founders Capital Management (Texas)
Texas
$15.6K – – –
WT
95
Whittier Trust
California
$15.6K – – –
FP
96
Financial Perspectives
Minnesota
$13.7K – – –
HWM
97
HighMark Wealth Management
Minnesota
$12.5K – – –
National Bank of Canada
98
National Bank of Canada
Quebec, Canada
$11.6K – – –
HCM
99
Hollencrest Capital Management
California
$10.9K – – –
WIM
100
Westside Investment Management
California
$10.1K +$10.4K +65 New
1 2 3
4
5

BBH Hedge Fund Activity: Q3 2023 in Review

110 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2023, worth a combined $152M — down 16% from $180M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BBH positions and 9 closed out — a net gain of 2 holders — while 19 added to existing stakes and 31 trimmed.

The largest buyer was Valley Wealth Managers, opening a new position worth an estimated $3.03M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $9.93M.

  • 110 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2023, down from 111 in Q2 2023.
  • Funds reported $152M of VanEck Biotech ETF stock for Q3 2023, down 16% quarter-over-quarter.
  • 11 funds opened new VanEck Biotech ETF positions in Q3 2023 and 9 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2023 was Valley Wealth Managers, an estimated $3.03M added.
  • The largest VanEck Biotech ETF seller in Q3 2023 was Qube Research & Technologies (QRT), an estimated $9.93M sold.

Based on aggregated 13F filings for Q3 2023.